The Medical Minute: Cervical cancer awareness

September 16, 2009 By John Messmer

(PhysOrg.com) -- Science has sought the “cause” of cancer for decades, and in the case of cervical cancer, the cause has been found. The cervix is the opening to the womb that is situated at the upper end of the vagina. Until recently the best approach to cervical cancer was to detect it early with a Pap test performed during a gynecologic examination. While the occurrence of advanced cervical cancer has dropped through widespread use of the Pap test, there are many women in the United States and millions worldwide who do not get or have access to Pap tests. This year in the United States, about 12,000 women will be diagnosed with cervical cancer. Almost 4,000 will die of the disease, which is easily detectable and easily cured, if found early.

The key to is prevention. We now know cervical cancer is caused by the (HPV). There are many strains of HPV - some cause common warts, but four strains are responsible for most cervical cancer and some others cause . Strains that infect the hands and feet do not infect the vagina or , and vice versa. HPV is contracted from other people. In the case of cervical HPV infections, it is contracted by sexual intercourse.

At least half of all sexually active people become infected with at least one strain of HPV. Fortunately, most of these are defeated by a healthy and never cause a problem. Some, however, go on to cause changes that lead to cervical cancer.

Since cervical cancer is sexually transmitted, the earlier begins and the more sex partners a woman has, the greater her risk. Condoms do not reduce risk as they do for other sexually transmitted diseases. Lesbians do not have a lower risk of cervical cancer than heterosexual women and also should be examined annually. Smoking and secondhand exposure increase the risk of cervical cancer, probably by tobacco’s deleterious effects on the immune system.

To reduce the risk of HPV infection in the first place, a vaccine has been approved by the Food and Drug Administration (FDA). The HPV vaccine provides protection against the two most common strains of cancer-causing HPV and two strains that cause genital warts. The three-dose series reduces the risk of cervical cancer by 70 percent and genital warts by 90 percent. Annual Pap tests are still needed, but the chance of an abnormal result is greatly reduced after the vaccine.

The recommendation for vaccination is girls between age nine and 26 years old, ideally before sexual activity, but not limited to those without prior sexual contact. Some argue that abstinence and limiting exposure to one sexual partner is better than a vaccine. Still, it is a risk for parents to withhold vaccination and hope their daughter will follow this restriction. Vaccines are like seat belts - it might not be needed, but if it is, it’s best to have it ahead of time.

One day, cervical cancer might be totally preventable. Until then, the risk of invasive cancer of the cervix can be reduced by vaccination of appropriate women, delay in onset of sexual activity and limiting partners, avoidance of tobacco and annual Pap exams.

More information on cervical cancer can be found at www.cdc.gov/cancer/cervical/

Provided by Pennsylvania State University (news : web)

Related Stories

Recommended for you

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.